Skip to main content

Featured

13 building plans approved in Nov

The Buildings Department approved 13 building plans in November - two on Hong Kong Island, six in Kowloon and five in the New Territories.   Of the approved plans, eight were for apartment and apartment-commercial developments, two for commercial developments, one for factory and industrial developments, and two for community services developments.   Consent was given for works to start on 11 building projects which will provide 210,471 sq m of gross floor area for domestic use involving 2,595 units and 83,060 sq m for non-domestic use.   Additionally, the department received notification of commencement of superstructure works for nine building projects.   The department also issued 16 occupation permits - three on Hong Kong Island, five in Kowloon and eight in the New Territories.   Buildings certified for occupation have 53,034 sq m of gross floor area for domestic use involving 1,355 units and 168,627 sq m for non-domestic use. http://dlvr.it/Sh3Dtw

Suspected adverse case explained

An expert committee today said a suspected serious adverse event following COVID-19 vaccination did not have a direct link with the jab.   The Expert Committee on Clinical Events Assessment Following COVID-19 Immunisation made the statement after it convened an urgent meeting to assess the case.   The 63-year-old man, who received a dose of the Sinovac COVID-19 vaccine on February 26, suffered from acute shortness of breath with cough and attended Queen Elizabeth Hospital by himself in the early morning of February 28. His condition worsened rapidly and he succumbed that morning.   According to the Hospital Authority, the patient was a heavy smoker, had a history of diabetes mellitus, hypertension, hyperlipidemia, obesity and suspected ischemic heart disease.   The preliminary autopsy information revealed that he had serious coronary heart disease which led to acute myocardial infarction and pulmonary oedema, resulting in respiratory failure before passing away.   Having considered the medical conditions and history of the patient as well as relevant clinical data, available information related to the vaccine and preliminary autopsy findings, the expert committee conducted a causality assessment based on the World Health Organization’s algorithm.   It considered that the patient’s death was not directly associated with the COVID-19 vaccination but noted that a full autopsy report would be required to conclude the assessment.   The Department of Health emphasised that based on available data, there is no particular safety concern detected from the Sinovac COVID-19 vaccine.   According to the product information of the vaccine, patients with uncontrolled severe chronic diseases should not receive the jab, the department said.   Patients with severe chronic illness should use the vaccine with caution and if necessary, delay vaccination until after a doctor’s assessment, it added.
http://dlvr.it/RtvK5m

Popular Posts